Product Description for PILRA
Rat anti Human PILRA 36H2.
Presentation: Purified
Product is tested for Immunoprecipitation, Western blot / Immunoblot, Flow Cytometry.
Presentation: Purified
Product is tested for Immunoprecipitation, Western blot / Immunoblot, Flow Cytometry.
Properties for PILRA
| Product Category | Primary Antibodies |
|---|---|
| Quantity | 50 µg |
| Synonyms | Cell surface receptor FDF03, FDF03, Inhibitory receptor PILR-alpha, PILR-alpha, Paired immunoglobulin-like type 2 receptor alpha |
| Presentation | Purified |
| Reactivity | Hu |
| Applications | F, IP, WB |
| Clonality | Monoclonal |
| Clone | 36H2 |
| Host | Rat |
| Isotype | IgG2a |
| Shipping to | Germany, USA/Canada |
| PDF datasheet | View Datasheet |
| Manufacturer | Dendritics SAS |
Datasheet Extract
| Immunogen |
|
|---|---|
| Isotype control | SM15P, SM15PX |
| Application | DDX0230P-50 / DDX0230P-100 Purified: Surface Flow cytometry, Immunoprecipitation, Western Blot. DDX0230A488-50 / DDX0230A488-100 Alexa-fluor®488: Surface Flow cytometry, ImmunoFluorescence. DDX0230A546-50 / DDX0230A546-100 Alexa-fluor®488: Surface Flow cytometry, ImmunoFluorescence. DDX0230A647-50 / DDX0230A647-100 Alexa-fluor®488: Surface Flow cytometry, ImmunoFluorescence. DDX0230B-50 / DDX0230B-100 Biotin: Western Blot. Usage recommendation: *This monoclonal antibody may be used between 5-20 μg/ml. *Optimal dilution should be determined by each laboratory for each application. *Coupled antibody: to maintain RT before use. |
| Background | Human FDF03, is a novel member of the Ig superfamily expressed as a monomeric 44 kDa transmembrane glycoprotein and containing a single extracellular V-set Ig-like domain. Two potential secreted isoforms were also identified. FDF03 was mostly detected in hemopoietic tissues and was expressed by monocytes, macrophages, and granulocytes, but not by lymphocytes (B, T, and NK cells), indicating an expression restricted to the myelomonocytic lineage. FDF03 was also strongly expressed by monocyte-derived dendritic cells (moDC) and preferentially by CD14+/CD1a- DC derived from CD34+ progenitors. Moreover, flow cytometric analysis showed FDF03 expression by CD11c+ blood and tonsil DC, but not by CD11c- DC precursors. The FDF03 cytoplasmic tail contained two immunoreceptor tyrosine-based inhibitory motifs (ITIM)-like sequences. Human FDF03 is a novel ITIM-bearing receptor selectively expressed by cells of myeloid origin, including DC, which may regulate functions other than that of the broadly distributed LAIR-1/p40 molecule. (Fournier N et al, 2000; J. Immunol., 165(3):1197-1209). |
| Concentration | 0.5 mg/ml |
| Product Citations |
|
| Storage | -20°C. KEEP CONTENTS STERILE: no preservative. Purified antibodies: avoid repeated freeze/thaw cycles. Coupled antibodies: glycerol protects from freezing. |
| Format |
|
| Specificity |
|
| Gene ID | 29992 |
Accessory Products
Proteins and/or Positive Controls
Proteins for PILRA (2 products)
| Catalog No. | Species | Pres. | Purity | Source | |||
|---|---|---|---|---|---|---|---|
| H00029992-P01-10 |
PILRA |
||||||
|
Human | 12.5% SDS-PAGE Stained with Coomassie Blue. | in vitro transl. | ||||
| Abnova Taiwan Corp. | |||||||
| H00029992-P01-25 |
PILRA |
||||||
|
|
Human | 12.5% SDS-PAGE Stained with Coomassie Blue. | in vitro transl. | ||||
| Abnova Taiwan Corp. | |||||||
Positive controls for PILRA (2 products)
| Catalog No. | Species | Pres. | Purity | Source | |||
|---|---|---|---|---|---|---|---|
| LY405991 |
PILRA overexpression lysate |
||||||
|
0.1 mg /
€295.00
|
||||||
| OriGene Technologies, Inc. | |||||||
| LY415539 |
PILRA overexpression lysate |
||||||
|
0.1 mg /
€295.00
|
||||||
| OriGene Technologies, Inc. | |||||||
Recommended Secondary Antibodies for PILRA (11 products)
| Catalog No. | Host | Clone/Iso. | Pres. | React. | Applications | ||
|---|---|---|---|---|---|---|---|
| R1371AP |
Rat IgG (H+L chain) antibody |
||||||
|
|
Rabbit | AP | |||||
| OriGene Technologies GmbH | |||||||
| R1371B |
Rat IgG (H+L chain) antibody |
||||||
|
|
Rabbit | Biotin | |||||
| OriGene Technologies GmbH | |||||||
| R1371F |
Rat IgG (H+L chain) antibody |
||||||
|
|
Rabbit | FITC | |||||
| OriGene Technologies GmbH | |||||||
| R1371HRP |
Rat IgG (H+L chain) antibody |
||||||
|
|
Rabbit | HRP | C, E, WB | ||||
| OriGene Technologies GmbH | |||||||
| R1371T |
Rat IgG (H+L chain) antibody |
||||||
|
|
Rabbit | TRITC | |||||
| OriGene Technologies GmbH | |||||||
| R1413R |
Rat IgG (H+L chain), F(ab)2 Fragment antibody |
||||||
|
|
Goat | PE | |||||
| OriGene Technologies GmbH | |||||||
| R1415R |
Rat IgG F(ab)2 specific (adsorbed F(ab)2 Fragment) antibody |
||||||
|
|
Goat | PE | |||||
| OriGene Technologies GmbH | |||||||
| R1428R |
Rat IgG (H+L chain) F(ab')2 Fragment antibody |
||||||
|
|
Donkey | PE | |||||
| OriGene Technologies GmbH | |||||||
| R1439C2 |
Rat IgG (H+L chain, adsorbed) antibody |
||||||
|
|
Goat | Cy2 | |||||
| OriGene Technologies GmbH | |||||||
| R1439C3 |
Rat IgG (H+L chain, adsorbed) antibody |
||||||
|
|
Goat | Cy3 | |||||
| OriGene Technologies GmbH | |||||||
| R1439C5 |
Rat IgG (H+L chain, adsorbed) antibody |
||||||
|
|
Goat | Cy5 | |||||
| OriGene Technologies GmbH | |||||||
Compare Products
You have no items to compare.
My Cart
You have no items in your shopping cart.
